论文部分内容阅读
本文主要根据近年来文献、法国围产医学专家J.Melchior1987年5月2日至15日来华讲学内容以及1987年6月1日至3日在美国新泽西召开的胎儿围产期的生化监护首届国际讨论会的内容,对国内外胎儿监护的现状作综述介绍。一、当前世界对高危孕妇胎儿的监护可分为三个阶段。 (一)胎心率电子监护(eloctronic FHRmonitoring,即胎心宫缩图cardiotocogrameCTG)。1960年开始使用后,对早期发现低氧征象,作为筛查手段很有价值,但仪器太敏感,胎儿存在低氧时,CTG基本上均出现可疑或病理图型;但出现可疑或病理图型并不一定有代谢性酸中毒存在,即假阳性率较高,约占60％;增加了不必要的剖宫产率及其它手术率。此为第一阶段的监护水平。
This article mainly based on recent literature, the French perinatal medical expert J.Melchior May 2, 1987 to 15 lectures in China and from June 1, 1987 to June 3 in New Jersey held in the United States, the first perinatal biochemical care International Symposium content, overview of the status quo of fetus monitoring at home and abroad. First, the current world of high-risk maternal fetus guardianship can be divided into three stages. (A) Fetal heart rate electronic monitoring (eloctronic FHRmonitoring, ie, fetal cardiotocogrameCTG). After the beginning of use in 1960, early detection of hypoxia was valuable as a screening tool, but the instrument was too sensitive. CTG basically showed suspicious or pathological patterns in the presence of fetal hypoxia; however, there was a suspicious or pathological pattern Metabolic acidosis does not necessarily exist, that is, a high false positive rate, accounting for about 60%; increased unnecessary cesarean section rate and other surgical rates. This is the first stage of guardianship level.